RPS19

RPS19 Full Name

ribosomal protein S19

RPS19 Introduction

Ribosomal protein S19 (RPS19) is an essential structural and functional component of the 40S small ribosomal subunit and one of the best-characterized ribosomal proteins associated with human ribosomopathies. Although traditionally viewed as a housekeeping protein involved in protein synthesis, growing evidence demonstrates that RPS19 performs highly specialized roles during ribosome biogenesis, particularly in precursor ribosomal RNA (pre-rRNA) processing, 18S rRNA maturation, and assembly of the 40S subunit. For researchers investigating inherited bone marrow failure syndromes, defective erythropoiesis, or translational regulation, RPS19 has become a central molecular target because even subtle alterations in its expression or function can disrupt ribosome assembly and trigger profound cellular stress responses. Recent mechanistic studies further show that the RNA-binding activity of RPS19 is indispensable for stable interaction with 18S rRNA and proper formation of the ribosomal decoding center, highlighting why RPS19 deficiency causes selective cellular vulnerability despite the universal requirement for ribosomes in all tissues.

The biological importance of RPS19 extends far beyond its structural role within mature ribosomes. During early ribosome assembly, RPS19 facilitates processing of pre-rRNA, promotes maturation of the 40S ribosomal subunit, and ensures efficient translation initiation. Pathogenic RPS19 variants impair incorporation of the protein into assembling ribosomes, resulting in defective 40S biogenesis, accumulation of immature rRNA intermediates, nucleolar stress, and activation of the p53 signaling pathway. Emerging experimental models have refined our understanding of these mechanisms by demonstrating that RPS19 haploinsufficiency preferentially induces p53-dependent apoptosis of hematopoietic stem and progenitor cells rather than alternative stress responses observed with other ribosomal protein deficiencies. Transcriptomic analyses further reveal widespread translational and transcriptional dysregulation, including increased RUNX1 expression, suggesting that impaired ribosome production influences lineage-specific gene regulatory networks in addition to global protein synthesis. These findings emphasize that RPS19 is both a fundamental ribosomal component and a critical regulator of stem cell maintenance and erythroid differentiation.

Clinically, RPS19 is most strongly associated with Diamond-Blackfan anemia (DBA), where heterozygous pathogenic variants account for approximately one-quarter of genetically confirmed cases, making it the most frequently mutated DBA gene. Patients typically present with congenital hypoplastic anemia during infancy, while some also develop craniofacial, skeletal, cardiac, or growth abnormalities that reflect the tissue-specific consequences of ribosomal dysfunction. Recent mouse models carrying disease-relevant RPS19 mutations, including the conserved R67Δ variant, closely reproduce human DBA phenotypes and demonstrate that defective erythropoiesis is accompanied by persistent pre-rRNA accumulation, sustained p53 activation, hematopoietic stem cell depletion, and impaired multilineage hematopoietic reconstitution. Complementary patient-derived induced pluripotent stem cell (iPSC) models carrying RPS19 mutations provide physiologically relevant platforms for studying disease progression, identifying biomarkers, and evaluating emerging therapeutic strategies, including p53 pathway modulation, gene correction, and targeted restoration of ribosome biogenesis. Together, these advances position RPS19 as both a clinically validated disease gene and a high-priority research target for understanding ribosome biology, hematopoietic failure, and the development of precision therapies for ribosomopathies.

Alternate Names for RPS19

RPS19; ribosomal protein S19; 40S ribosomal protein S19; DBA; Diamond Blackfan anemia; S19; DBA1;

• 1.Catalanotto C, et al.; The RNA-Binding Function of Ribosomal Proteins and Ribosome Biogenesis Factors in Human Health and Disease. Biomedicines. 2023, 11(11):2969.
  2.Blanc L, et al.; RPS19 and RPL5 Haploinsufficient Models Reveal Divergent Ribosomal Subunit Controls of Fetal Hematopoiesis. Res Sq [Preprint]. 2025, rs.3.rs-7563799.